The Effect of Dissemination Pathways on Uptake and Relative Costs for a Transdiagnostic, Self-guided Internet Intervention for Reducing Depression, Anxiety, and Suicidal Ideation: Comparative Implementation Study.
adherence
implementation
internet
mental health
uptake
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
06 05 2022
06 05 2022
Historique:
received:
08
11
2021
accepted:
04
04
2022
revised:
27
01
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
Self-guided web-based programs are effective; however, inadequate implementation of these programs limits their potential to provide effective and low-cost treatment for common mental health problems at scale. There is a lack of research examining optimal methods for the dissemination of web-based programs in the community. This study aimed to compare the uptake, reach, relative costs, and adherence associated with 3 community-based pathways for delivering a low-intensity web-based transdiagnostic mental health program. The 3 dissemination pathways were social media advertising, advertising in general practice, and advertising in pharmacies. Participants were recruited on the web, from general practices, or from community pharmacies; completed a screener for psychological distress; and were offered the 4-week FitMindKit program-a 12-module psychotherapeutic intervention. Uptake was defined as the number of participants who enrolled in the web-based program; reach was defined as the rate of uptake per exposure; and costs were calculated based on staff time, equipment, and advertising. Adherence was assessed as the number of modules of FitMindKit completed by the participants. Uptake comprised 1014 participants who were recruited through the 3 dissemination pathways: on the web (991/1014, 97.73%), in general practice (16/1014, 1.58%), and in pharmacy (7/1014, 0.69%). Reach was highest for social media: 1 in every 50 people exposed to web-based advertising took up the intervention compared with 1 in every 441 in general practitioner clinics and 1 in every 1708 in pharmacies. The dissemination cost was US $4.87 per user on social media, US $557 per user for general practitioner clinics, and US $1272 per user for pharmacy dissemination. No significant differences in adherence were observed between the conditions, whereas all pathways showed an underrepresentation of men and linguistic diversity. The web-based dissemination pathway was the most efficient and cost-effective for delivering a self-guided internet-based mental health program to people in the community. More research is needed to identify how best to engage men and those with culturally diverse backgrounds in web-based interventions. Australian New Zealand Clinical Trials Registry ACTRN12618001688279; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376113.
Sections du résumé
BACKGROUND
Self-guided web-based programs are effective; however, inadequate implementation of these programs limits their potential to provide effective and low-cost treatment for common mental health problems at scale. There is a lack of research examining optimal methods for the dissemination of web-based programs in the community.
OBJECTIVE
This study aimed to compare the uptake, reach, relative costs, and adherence associated with 3 community-based pathways for delivering a low-intensity web-based transdiagnostic mental health program. The 3 dissemination pathways were social media advertising, advertising in general practice, and advertising in pharmacies.
METHODS
Participants were recruited on the web, from general practices, or from community pharmacies; completed a screener for psychological distress; and were offered the 4-week FitMindKit program-a 12-module psychotherapeutic intervention. Uptake was defined as the number of participants who enrolled in the web-based program; reach was defined as the rate of uptake per exposure; and costs were calculated based on staff time, equipment, and advertising. Adherence was assessed as the number of modules of FitMindKit completed by the participants.
RESULTS
Uptake comprised 1014 participants who were recruited through the 3 dissemination pathways: on the web (991/1014, 97.73%), in general practice (16/1014, 1.58%), and in pharmacy (7/1014, 0.69%). Reach was highest for social media: 1 in every 50 people exposed to web-based advertising took up the intervention compared with 1 in every 441 in general practitioner clinics and 1 in every 1708 in pharmacies. The dissemination cost was US $4.87 per user on social media, US $557 per user for general practitioner clinics, and US $1272 per user for pharmacy dissemination. No significant differences in adherence were observed between the conditions, whereas all pathways showed an underrepresentation of men and linguistic diversity.
CONCLUSIONS
The web-based dissemination pathway was the most efficient and cost-effective for delivering a self-guided internet-based mental health program to people in the community. More research is needed to identify how best to engage men and those with culturally diverse backgrounds in web-based interventions.
TRIAL REGISTRATION
Australian New Zealand Clinical Trials Registry ACTRN12618001688279; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376113.
Identifiants
pubmed: 35522458
pii: v24i5e34769
doi: 10.2196/34769
pmc: PMC9123540
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e34769Informations de copyright
©Philip J Batterham, Amelia Gulliver, Ella Kurz, Louise M Farrer, Christiaan Vis, Josien Schuurmans, Alison L Calear. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 06.05.2022.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychol Med. 2014 Apr;44(6):1303-17
pubmed: 23931656
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
J R Soc Med. 2011 Dec;104(12):510-20
pubmed: 22179294
Trials. 2020 Oct 28;21(1):893
pubmed: 33115545
JAMA Psychiatry. 2021 Apr 1;78(4):361-371
pubmed: 33471111
Int J Methods Psychiatr Res. 2017 Dec;26(4):
pubmed: 28370638
Internet Interv. 2016 Apr 27;4:72-81
pubmed: 30135792
Annu Rev Public Health. 2009;30:151-74
pubmed: 19705558
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Internet Interv. 2019 Mar 11;17:100240
pubmed: 30963031
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079
PLoS One. 2014 Feb 28;9(2):e90311
pubmed: 24587318
BMC Psychiatry. 2014 Apr 11;14:109
pubmed: 24725765
Suicide Life Threat Behav. 2014 Aug;44(4):408-19
pubmed: 24612048
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
Aust N Z J Psychiatry. 2009 Jul;43(7):594-605
pubmed: 19530016
Aust N Z J Psychiatry. 2015 Sep;49(9):776-84
pubmed: 25907269
Am J Psychiatry. 2008 Jun;165(6):703-11
pubmed: 18463104
Aust N Z J Psychiatry. 2009 Jul;43(7):615-23
pubmed: 19530018
J Anxiety Disord. 2017 Mar;46:1-3
pubmed: 28249669
J Med Internet Res. 2021 Jan 22;23(1):e22698
pubmed: 33480860
JMIR Ment Health. 2017 Jun 30;4(2):e26
pubmed: 28666976
Sci Rep. 2018 Feb 12;8(1):2861
pubmed: 29434331
Annu Rev Clin Psychol. 2016;12:157-79
pubmed: 26652054
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Psychol Med. 2018 Jun;48(8):1316-1324
pubmed: 28967345
Psychol Med. 2018 Nov;48(15):2456-2466
pubmed: 29540243
JAMA. 2007 Jan 24;297(4):403-6
pubmed: 17244837
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
World Psychiatry. 2007 Oct;6(3):177-85
pubmed: 18188443
Psychol Med. 2011 Aug;41(8):1751-61
pubmed: 21134315
Res Social Adm Pharm. 2021 Mar;17(3):595-605
pubmed: 32448767
Depress Anxiety. 2018 Mar;35(3):195-208
pubmed: 29356216
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
JAMA Psychiatry. 2017 Apr 01;74(4):351-359
pubmed: 28241179
Cogn Behav Ther. 2017 Jan;46(1):1-28
pubmed: 27712544
PLoS One. 2017 Feb 27;12(2):e0172741
pubmed: 28241025
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
Contemp Clin Trials Commun. 2019 Mar 07;14:100341
pubmed: 30911696
JAMA Psychiatry. 2019 Jul 1;76(7):700-707
pubmed: 30994877
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
J Med Internet Res. 2021 Jul 27;23(7):e23029
pubmed: 34313595
J Med Internet Res. 2019 May 24;21(5):e12793
pubmed: 31127718
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
J Psychiatr Res. 2008 Jul;42(9):708-16
pubmed: 18331741
J Med Internet Res. 2020 Aug 31;22(8):e18100
pubmed: 32865497
Med J Aust. 2010 Jun 7;192(S11):S4-11
pubmed: 20528707
J Med Internet Res. 2016 Sep 08;18(9):e236
pubmed: 27608548
Patient Prefer Adherence. 2008 Feb 02;2:97-105
pubmed: 19920949
J Affect Disord. 2015 May 1;176:9-17
pubmed: 25682378
Lancet. 2003 Oct 11;362(9391):1225-30
pubmed: 14568747
Aust J Gen Pract. 2018 Apr;47(4):168-172
pubmed: 29621855
Internet Interv. 2017 Aug 23;12:91-99
pubmed: 30135773
J Clin Epidemiol. 2016 Mar;71:35-42
pubmed: 26464194